Windward Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16M | Sell |
32,004
-313
| -1% | -$150K | 1.22% | 23 |
|
|
2026
Q1 | $15.9M | Sell |
32,317
-608
| -2% | -$330K | 1.29% | 24 |
|
|
2025
Q4 | $19.1M | Sell |
32,925
-1,141
| -3% | -$645K | 1.51% | 20 |
|
|
2025
Q3 | $16.5M | Sell |
34,066
-344
| -1% | -$160K | 1.32% | 25 |
|
|
2025
Q2 | $14M | Sell |
34,410
-211
| -0.6% | -$88.2K | 1.18% | 26 |
|
|
2025
Q1 | $17.2M | Sell |
34,621
-539
| -2% | -$292K | 1.49% | 24 |
|
|
2024
Q4 | $18.3M | Sell |
35,160
-452
| -1% | -$249K | 1.4% | 23 |
|
|
2024
Q3 | $22M | Sell |
35,612
-208
| -0.6% | -$123K | 1.68% | 19 |
|
|
2024
Q2 | $19.8M | Sell |
35,820
-949
| -3% | -$544K | 1.67% | 20 |
|
|
2024
Q1 | $21.4M | Sell |
36,769
-506
| -1% | -$284K | 1.78% | 20 |
|
|
2023
Q4 | $19.8M | Sell |
37,275
-89
| -0.2% | -$43.1K | 1.72% | 21 |
|
|
2023
Q3 | $18.9M | Sell |
37,364
-779
| -2% | -$415K | 1.85% | 21 |
|
|
2023
Q2 | $19.9M | Buy |
38,143
+208
| +0.5% | +$112K | 1.8% | 21 |
|
|
2023
Q1 | $21.9M | Buy |
37,935
+893
| +2% | +$503K | 2.02% | 17 |
|
|
2022
Q4 | $20.4M | Sell |
37,042
-187
| -0.5% | -$99.1K | 2.21% | 19 |
|
|
2022
Q3 | $18.9M | Buy |
37,229
+64
| +0.2% | +$35.8K | 2.14% | 18 |
|
|
2022
Q2 | $20.2M | Buy |
37,165
+239
| +0.6% | +$132K | 2.17% | 17 |
|
|
2022
Q1 | $21.8M | Sell |
36,926
-84
| -0.2% | -$48.3K | 1.95% | 17 |
|
|
2021
Q4 | $24.7M | Buy |
37,010
+57
| +0.2% | +$35.6K | 2.05% | 15 |
|
|
2021
Q3 | $21.1M | Sell |
36,953
-99
| -0.3% | -$54.3K | 1.96% | 18 |
|
|
2021
Q2 | $18.7M | Sell |
37,052
-77
| -0.2% | -$36.3K | 1.74% | 21 |
|
|
2021
Q1 | $16.9M | Buy |
37,129
+19,769
| +114% | +$9.44M | 1.69% | 22 |
|
|
2020
Q4 | $8.09M | Buy |
17,360
+16,258
| +1,475% | +$7.62M | 0.81% | 31 |
|
|
2020
Q3 | $487K | Sell |
1,102
-14
| -1% | -$5.78K | 0.05% | 68 |
|
|
2020
Q2 | $404K | Sell |
1,116
-11
| -1% | -$3.69K | 0.05% | 68 |
|
|
2020
Q1 | $320K | Sell |
1,127
-92
| -8% | -$29K | 0.04% | 67 |
|
|
2019
Q4 | $396K | Sell |
1,219
-8
| -0.7% | -$2.43K | 0.04% | 71 |
|
|
2019
Q3 | $357K | Sell |
1,227
-42
| -3% | -$12K | 0.04% | 74 |
|
|
2019
Q2 | $373K | Sell |
1,269
-31
| -2% | -$8.54K | 0.05% | 71 |
|
|
2019
Q1 | $356K | Sell |
1,300
-10
| -0.8% | -$2.49K | 0.05% | 70 |
|
|
2018
Q4 | $293K | Sell |
1,310
-26
| -2% | -$6.1K | 0.04% | 72 |
|
|
2018
Q3 | $326K | Buy |
+1,336
| New | +$307K | 0.04% | 73 |
|
Other funds holding TMO
Windward Capital Management's TMO Position: Q2 2026 in Review
Windward Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.97% in Q2 2026, selling an estimated $150K and leaving 32,004 shares worth $16M. The position accounts for 1.22% of the portfolio, ranked #23.
Windward Capital Management first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $24.7M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Windward Capital Management held 32,004 shares of Thermo Fisher Scientific worth $16M as of Q2 2026.
- Windward Capital Management sold 313 Thermo Fisher Scientific shares in Q2 2026, an estimated $150K.
- Thermo Fisher Scientific made up 1.22% of Windward Capital Management's portfolio in Q2 2026, its #23 holding.
- Windward Capital Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- Windward Capital Management's Thermo Fisher Scientific position peaked at $24.7M in Q4 2021.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Windward Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.